Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01433328
Recruitment Status : Terminated (Safety considerations)
First Posted : September 13, 2011
Last Update Posted : April 5, 2012
Information provided by (Responsible Party):
Dr David Langleben, Jewish General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : April 2012